About John Kraft, II
Form D filings for Lila Biologics in 2023 list John Kraft, II as chief executive officer and director.
John Kraft, II first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name John Kraft, II in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Kraft, II works with at each company, as listed on that company's latest Form D.
Lila Biologics, Inc. · Form D, Sep 28, 2023